Kanat, O. Et Al. 2003. Single-agent irinotecan as second-line treatment for advanced gastric cancer. TUMORI JOURNAL , vol.89, no.4 , 405-407.

Kanat, O., Evrensel, T., Manavoglu, O., Demiray, M., Kurt, E., Gonullu, G., ... Kiyici, M.(2003). Single-agent irinotecan as second-line treatment for advanced gastric cancer. TUMORI JOURNAL , vol.89, no.4, 405-407.

Kanat, O Et Al. "Single-agent irinotecan as second-line treatment for advanced gastric cancer," TUMORI JOURNAL , vol.89, no.4, 405-407, 2003

Kanat, O Et Al. "Single-agent irinotecan as second-line treatment for advanced gastric cancer." TUMORI JOURNAL , vol.89, no.4, pp.405-407, 2003

Kanat, O. Et Al. (2003) . "Single-agent irinotecan as second-line treatment for advanced gastric cancer." TUMORI JOURNAL , vol.89, no.4, pp.405-407.

@article{article, author={O Kanat Et Al. }, title={Single-agent irinotecan as second-line treatment for advanced gastric cancer}, journal={TUMORI JOURNAL}, year=2003, pages={405-407} }